Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2002 10:24 ET | Source: GenOdyssee SA

GenOdyssee Announces Positive Results of Proprietary Interferon-alpha Variants for the Treatment of Hepatitis C and Cancer; In Preclinical Disease Models Variants Demonstrate Increased Efficacy Compared to Those Currently Available on the Market

PARIS, France, Sept. 5, 2002 (PRIMEZONE) -- GenOdyssee S.A., a biotherapeutics company specializing in discovering and developing drugs from functional genomics, today announced preclinical results...